GEN
GENOMED NEWCONNECT LISTED

Shareholders

as of September 20, 2026 · source: notifications under Art. 69 of the Offering Act · 4 entities above 5%

FREE FLOAT
23.98%
LARGEST STAKE
41.17%
Diagnostyka Spółka Akcyjna
TOP 3 CONCENTRATION
70.42%
3 entities above 5%
LATEST CHANGE
June 30, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications
SHAREHOLDERS ≥5% 76.02% FREE FLOAT 23.98%
Diagnostyka Spółka Akcyjna 41.17%
543,963 shares · notification August 16, 2026
Marek Zagulski 20.07%
265,228 shares · notification August 16, 2026
Anna Boguszewska-Chachulska 9.18%
121,236 shares · notification August 16, 2026
Iwona Wach 5.6%
74,000 shares · notification August 16, 2026
FREE FLOAT — BELOW 5% THRESHOLD
Andrzej Migdalski 6.74%
65,498 shares · notification August 16, 2026
Andrzej Pałucha 6.81%
65,420 shares · notification August 16, 2026
Other 14.07%
— · composition undisclosed

Capital and votes

Number of shares
ISIN
PLGNOMD00024
Sector
Biotechnologia
Market
NEWCONNECT
Country
PL
Listing date
May 17, 2026

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.